Peptide Therapeutics Market Size Worth USD 75.92 Billion in 2032 | Emergen Research

The global peptide therapeutics market size was USD 42.70 Billion in 2022 and is expected to register a revenue CAGR of 6.0% during the forecast period. The global peptide therapeutics market is experiencing significant growth driven by increasing funding and investments in the development of novel drugs, alongside remarkable technological advancements in peptide therapeutics. Peptides, short chains of amino acids, are crucial in various biological processes and offer promising solutions for preventing and treating a wide array of diseases and conditions.

Key Market Drivers

1. Escalating Prevalence of Cancer: The rising incidence of cancer, which is a leading cause of mortality globally, is fueling the growth of the peptide therapeutics market. With cancer cases reaching alarming numbers, peptide-based therapies emerge as a promising approach due to their ability to target specific cancer cells while minimizing harm to healthy tissues.
2. Technological Advancements: Innovations such as peptide drug conjugates and cell-penetrating peptides are enhancing the efficacy of peptide therapeutics, enabling the development of drugs that precisely target cancer cells while minimizing side effects.
3. Innovative Delivery Systems: Novel delivery systems like nanoparticles and liposomes are revolutionizing peptide therapeutics, making them more effective and with fewer side effects. These advancements are paving the way for a new generation of peptide-based drugs.
4. Rising Collaborations: Collaborations between industry leaders, such as the recent partnership between Sumitovant and Neochromosome, are driving the discovery, development, and commercialization of peptide drugs, leveraging advanced technologies like artificial intelligence (AI) for accelerated drug development.

Get Free Sample Report and Related Graphs & Charts @ https://www.emergenresearch.com/request-sample/2736

Market Restraints

Despite the promising growth prospects, challenges such as the high cost of drugs and access to affordable medicines in low/middle-income countries pose restraints to market growth. Additionally, the longer development timelines and limitations in stability and half-life of peptides compared to traditional small molecule drugs hinder market expansion.

Insights by Type

• Innovative Peptides: Dominating the market, innovative peptides offer advantages like higher purity, consistency, and extensive clinical data, making them preferred options for pharmaceutical companies.
• Generic Peptides: Expected to witness moderate growth, technological advancements in generic peptide therapeutics contribute to making peptide drugs more affordable after the expiration of patents for innovative peptides.

Application Insights

• Cancer Treatment: Expected to hold a significant market share, peptides are extensively used in cancer therapeutics due to their ability to target various cancer cell receptors, promising advancements like the launch of CBX-15 for breast cancer treatment further driving growth.
• Metabolic Disorders: Steadily growing due to rising prevalence of disorders like diabetes and obesity, peptide therapeutics offer effective treatment options for metabolic diseases.

Get An Impressive Discount On This Report@ https://www.emergenresearch.com/request-discount/2736

Route of Administration and Manufacturer Insights

• Parenteral Administration: Accounting for the largest market share, parenteral administration ensures optimal absorption and higher bioavailability, crucial for delivering peptides directly into the bloodstream.
• In-house Manufacturing: Expected to register the fastest growth, in-house manufacturing allows companies to retain control over intellectual property, facilitating customization and efficient drug development.

Peptide Therapeutics Top Companies and Competitive Landscape

The global peptide therapeutics market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective peptide therapeutics solutions.

Some major players included in the global peptide therapeutics market report are:

• AstraZeneca
• Amgen Inc.
• GSK plc.
• Pfizer Inc.
• Sanofi
• AbbVie Inc.
• Bristol Myers Squibb Company
• Eli Lilly and Company
• Novartis AG
• Baush Health companies Inc.

Peptide Therapeutics Latest Industry News

• On 22 June 2023, IRBM collaborated with Merck & Co. Inc. to continue their development in the peptide therapeutics area. The utilization of novel technologies, such as phage display peptide libraries and half-life extension strategies, has accelerated the development of peptide candidates with enhanced therapeutic potential. This collaboration has taken advantage of these novel technologies to develop peptide candidates that progress into the clinic.

• On 31 May 2022, Sapience Therapeutics announced the development of peptide therapeutics to address difficult-to-treat cancers.ST101, a first-in-class antagonist evaluated in the Phase 2 portion of an ongoing Phase 1-2 clinical study in patients with advanced unresectable and metastatic solid tumors. This is an advanced treatment for metastatic hormone-receptor positive breast cancer and castration-resistant prostate cancer.

Buy The Full Research Report At @ https://www.emergenresearch.com/select-license/2736

Peptide Therapeutics Market Segment Analysis

For the purpose of this report, Emergen Research has segmented the global peptide therapeutics market on the basis of type, application, route of administrations, type of manufacturers, distribution channel, and region:

• Type Outlook (Revenue, USD Billion; 2019-2032)
o Innovative
o Generic
• Application Outlook (Revenue, USD Billion; 2019-2032)
o Metabolic Disorder
o Respiratory Disorders
o Cancer
o Cardiovascular
o Immunological
o Neurological Disorders
o Gastrointestinal (GI) Disorders
o Renal Disorders
o Others
• Route of Administration Outlook (Revenue, USD Billion; 2019-2032)
o Parenteral Route
o Pulmonary
o Oral Route
o Mucosal
o Others
• Type of manufacturers Outlook (Revenue, USD Billion; 2019-2032)
o In-house
o Outsourced
• Distribution Channel Outlook (Revenue, USD Billion; 2019-2032)
o Hospital Pharmacies
o Drug Store and Retail Pharmacies
o Online Pharmacies

To Get Leading Market Solutions, Visit The Link Below: https://www.emergenresearch.com/industry-report/peptide-therapeutics-market

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.